I E Smith Selected Research

I E Smith Research Topics

Disease

39	Breast Neoplasms (Breast Cancer) 07/2017 - 02/2000
12	Neoplasms (Cancer) 07/2017 - 02/2000
5	Disease Progression 03/2011 - 02/2000
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2004 - 12/2000
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2004 - 10/2000
3	Triple Negative Breast Neoplasms 01/2017 - 11/2008
3	Mesothelioma 09/2004 - 10/2000
2	Cardiotoxicity 12/2015 - 12/2001
2	Sepsis (Septicemia) 12/2006 - 06/2000
2	Malignant Mesothelioma 09/2004 - 02/2002
2	Nausea 04/2004 - 07/2001
2	Melanoma (Melanoma, Malignant) 10/2000 - 02/2000
2	Inflammatory Breast Neoplasms 09/2000 - 06/2000
2	Necrosis 02/2000 - 01/2000
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2017
1	Neoplasm Metastasis (Metastasis) 04/2016
1	Brain Neoplasms (Brain Tumor) 04/2016
1	Residual Neoplasm 01/2015
1	Primary Ovarian Insufficiency 01/2013
1	Infertility (Sterility) 01/2013
1	Proteinuria 03/2011
1	Hemorrhage 03/2011
1	Hypertension (High Blood Pressure) 03/2011
1	Venous Thromboembolism 03/2011
1	Frailty 10/2010
1	Neutropenia 01/2009
1	Male Breast Neoplasms (Male Breast Cancer) 03/2007
1	Ductal Carcinoma 07/2006
1	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2006
1	Bone Resorption 10/2005
1	Lung Neoplasms (Lung Cancer) 05/2004
1	Weight Loss (Weight Reduction) 05/2004
1	Premature Menopause 12/2003
1	Chronic Obstructive Pulmonary Disease (COPD) 07/2003
1	Respiratory Insufficiency (Respiratory Failure) 10/2002
1	Exanthema (Rash) 07/2001
1	Vomiting 07/2001
1	Mucositis 07/2001
1	Small Cell Carcinoma 01/2001

Drug/Important Bio-Agent (IBA)

7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2010 - 10/2000
6	Cisplatin (Platino)FDA LinkGeneric 08/2010 - 03/2001
6	Epirubicin (Ellence)FDA LinkGeneric 08/2010 - 10/2000
5	Vinblastine (Vinblastine Sulfate)FDA Link 02/2005 - 01/2001
5	Mitomycin (Mitomycin-C)FDA LinkGeneric 02/2005 - 01/2001
4	Estrogen ReceptorsIBA 07/2017 - 12/2009
4	Trastuzumab (Herceptin)FDA Link 04/2016 - 12/2001
4	AnthracyclinesIBA 03/2011 - 07/2001
4	Fluorouracil (Carac)FDA LinkGeneric 08/2010 - 06/2000
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2009 - 05/2004
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 08/2011
3	Pharmaceutical PreparationsIBA 01/2017 - 06/2000
3	Aromatase InhibitorsIBA 03/2014 - 03/2007
3	Capecitabine (Xeloda)FDA Link 10/2010 - 08/2007
3	SRL172IBA 02/2002 - 10/2000
2	Progesterone Receptors (Progesterone Receptor)IBA 08/2011 - 12/2009
2	Estradiol (Delestrogen)FDA LinkGeneric 03/2007 - 10/2005
2	Hormones (Hormone)IBA 03/2007 - 07/2006
2	LipidsIBA 10/2005 - 04/2004
2	Vinorelbine (Navelbine)FDA LinkGeneric 09/2005 - 06/2003
2	Peptides (Polypeptides)IBA 03/2005 - 02/2000
2	Carboplatin (JM8)FDA LinkGeneric 06/2003 - 01/2001
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2000 - 01/2000
1	Methotrexate (Mexate)FDA LinkGeneric 04/2016
1	Goserelin (Zoladex)FDA Link 01/2013
1	Bevacizumab (Avastin)FDA Link 03/2011
1	taxaneIBA 03/2011
1	human ERBB2 proteinIBA 03/2011
1	Trinitrotoluene (TNT)IBA 01/2010
1	pegfilgrastim (Neulasta)FDA Link 01/2009
1	PlatinumIBA 11/2008
1	Letrozole (Femara)FDA LinkGeneric 03/2007
1	CholesterolIBA 10/2005
1	HDL CholesterolIBA 10/2005
1	Keratins (Keratin)IBA 03/2005
1	Keratin-19 (Keratin 19)IBA 03/2005
1	ProlactinIBA 03/2005
1	Tamoxifen FDA LinkGeneric 04/2004
1	idoxifeneIBA 04/2004
1	Monoclonal AntibodiesIBA 04/2004
1	Biological ProductsIBA 12/2003
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2002
1	Proteins (Proteins, Gene)FDA Link 12/2001
1	Epidermal Growth Factor (EGF)IBA 12/2001
1	Dexamethasone (Maxidex)FDA LinkGeneric 07/2001
1	Transaminases (Aminotransferases)IBA 07/2001
1	Pemetrexed (MTA)FDA Link 07/2001
1	Taxoids (Taxanes)IBA 07/2001

Therapy/Procedure

25	Drug Therapy (Chemotherapy) 01/2017 - 02/2000
11	Therapeutics 01/2017 - 09/2000
7	Neoadjuvant Therapy 01/2015 - 02/2000
5	Adjuvant Chemotherapy 07/2017 - 10/2003
2	Radiotherapy 04/2016 - 12/2003
2	Mechanical Ventilators (Ventilator) 07/2003 - 10/2002
2	Combination Drug Therapy (Combination Chemotherapy) 10/2000 - 06/2000
2	Injections 10/2000 - 10/2000
1	Immunotherapy 01/2017
1	Drug Tapering 10/2010
1	Lasers (Laser) 03/2005
1	Combined Modality Therapy 04/2004
1	Intermittent Positive-Pressure Ventilation 07/2003